POTENCY AND SELECTIVITY OF THE NON-STEROIDAL AROMATASE INHIBITOR CGS 16949A IN POSTMENOPAUSAL BREAST CANCER PATIENTS
Author:
Publisher
Wiley
Subject
Endocrinology, Diabetes and Metabolism,Endocrinology
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2265.1990.tb00906.x/fullpdf
Reference32 articles.
1. Inactivation of aromatase in vitro by 4-hydroxy-4-androstene-3,17-dione and 4-acetoxy-4-androstene-3,17-dione and sustained effects in vivo
2. 4-HYDROXYANDROSTENEDIONE IN TREATMENT OF POSTMENOPAUSAL PATIENTS WITH ADVANCED BREAST CANCER
3. Oral 4-hydroxyandrostenedione, a new endocrine treatment for disseminated breast cancer
4. Endocrine Changes Associated with Relapse in Advanced Breast Cancer Patients on Aminoglutethimide Therapy
5. OESTROGEN-RELATED CHANGES IN SEX HORMONE BINDING GLOBULIN LEVELS DURING NORMAL AND GONADOTROPHIN-STIMULATED MENSTRUAL CYCLES
Cited by 83 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Aromatase Inhibitors Evolution as Potential Class of Drugs in the Treatment of Postmenopausal Breast Cancer Women;Mini-Reviews in Medicinal Chemistry;2018-03-26
2. Recent Progress in the Discovery of Next Generation Inhibitors of Aromatase from the Structure–Function Perspective;Journal of Medicinal Chemistry;2016-01-19
3. Estradiol measurement in translational studies of breast cancer;Steroids;2015-07
4. Ineffective Inhibition of Aromatase: A Cause for AI Resistance?;Resistance to Targeted Anti-Cancer Therapeutics;2015
5. Understanding response and resistance to oestrogen deprivation in ER-positive breast cancer;Molecular and Cellular Endocrinology;2014-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3